Summary
The United States District Court for the Northern District of California grants Defendants’ second motion to dismiss a putative securities class action concerning SentinelOne’s reporting of Annualized Recurring Revenue. The Court concludes that the Second Amended Complaint fails to plead a strong inference of scienter under the heightened requirements applicable to Exchange Act claims, including based on alleged ARR methodology changes, accounting errors, insider trading, the Attivo merger, and the core operations doctrine.
Holdings
- The complaint did not adequately plead a strong inference of scienter merely by alleging that SentinelOne later corrected ARR calculations or had changed its ARR methodology without disclosure. Those allegations supported, at most, the possibility of accounting errors or unintentional misleading conduct, not knowing or deliberate recklessness.
- The alleged stock sales by Tomer Weingarten and David Bernhardt did not support a strong inference of scienter because the allegations did not show that the sales were dramatically out of line with prior trading practices or timed to maximize the benefits of undisclosed information.
- The alleged motive to inflate SentinelOne’s stock price in connection with the Attivo merger did not support a strong inference of scienter.
- The core operations doctrine did not establish scienter because Plaintiff failed to allege specific admissions or witness accounts showing that the individual defendants were involved in creating the allegedly false ARR reports or knew of the underlying inaccuracies.
- The Section 20(a) claim failed because Plaintiff failed to adequately plead the necessary primary violation of Section 10(b).
- Leave to amend was denied because Plaintiff had already received an opportunity to amend and had failed to cure the previously identified pleading deficiencies.
Questions Presented
- Whether the Second Amended Complaint adequately pleaded scienter under Section 10(b), Rule 10b-5, and the PSLRA based on SentinelOne’s ARR methodology, alleged double counting, insider stock sales, the Attivo merger, and the core operations doctrine.
- Whether Plaintiff’s Section 20(a) control-person claim survived when the complaint failed to adequately plead a primary Section 10(b) violation.
- Whether Plaintiff should be granted leave to amend after previously receiving an opportunity to cure pleading deficiencies.
Disposition
dismissed
Cases Cited (19)
- Mendiondo v. Centinela Hosp. Med. Ctr., 521 F.3d 1097, 1104 (9th Cir. 2008)(followed)
- Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007)(followed)
- Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009)(followed)
- Manzarek v. St. Paul Fire & Marine Ins. Co., 519 F.3d 1025, 1031 (9th Cir. 2008)(followed)
- In re Gilead Scis. Secs. Litig., 536 F.3d 1049, 1055 (9th Cir. 2008)(followed)
- In re Rigel Pharm., Inc. Sec. Litig., 697 F.3d 869, 876 (9th Cir. 2012)(followed)
- Zucco Partners, LLC v. Digimarc Corp., 552 F.3d 981, 990–91, 1007 (9th Cir. 2009), as amended (Feb. 10, 2009)(followed)
- Stoneridge Inv. Partners, LLC v. Scientific-Atlanta, Inc., 552 U.S. 148, 157 (2008)(followed)
- Schueneman v. Arena Pharm. Inc., 840 F.3d 698, 705 (9th Cir. 2016)(followed)
- Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308, 324 (2007)(followed)
Showing top 10 of 19.
Cited In (0)
No citing cases on record yet.